Povidone Iodine Market

By Formulation Type;

Scrub, Topical Solution, Ointments, and Others

By Type;

Medical Grade and Industrial Grade.

By Application;

Skin Sterilization , Infection Prevention, Instrument Sterilization, and Others.

By End User;

Hospitals, Clinics, Ambulatory Surgical Centers, Pharmacies, and Home Care Settings.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn715344537 Published Date: August, 2025

Povidone Iodine Market Overview

Povidone Iodine Market (USD Million)

Povidone Iodine Market was valued at USD 166.69 million in the year 2024. The size of this market is expected to increase to USD 213.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.6%.


Povidone Iodine Market

*Market size in USD million

CAGR 3.6 %


Study Period2025 - 2031
Base Year2024
CAGR (%)3.6 %
Market Size (2024)USD 166.69 Million
Market Size (2031)USD 213.51 Million
Market ConcentrationHigh
Report Pages323
166.69
2024
213.51
2031

Major Players

  • BASF SE
  • Glide Chem Private Limited
  • Adani Pharmachem Private Limited
  • Boai NKY Pharmaceuticals Ltd.
  • LASA Supergenerics Limited
  • Medline Industries, Inc.
  • R.N. LABORATORIES PVT. LTD.
  • Samrat Pharmachem Limited
  • Avrio Health L.P.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Povidone Iodine Market

Fragmented - Highly competitive market without dominant players


The Povidone Iodine Market is witnessing consistent growth, fueled by its vital role as a broad-spectrum antiseptic and disinfectant. It is widely utilized in surgeries, wound care, and infection prevention measures, contributing to over 55% of healthcare-related disinfection usage. Its critical importance in maintaining hygiene and safety is boosting its demand across diverse applications.

Growing utilization in healthcare
The need for effective infection control has increased reliance on povidone iodine in hospitals and clinical practices. Over 45% of wound care solutions integrate povidone iodine due to its proven antimicrobial effectiveness. Its availability in multiple forms such as scrubs, ointments, and liquid solutions enhances adaptability, making it a trusted choice among medical professionals. Rising awareness of infection control is further accelerating its demand.

Technological improvements in formulations
Advancements in formulations are shaping the market’s future by offering improved stability and targeted efficacy. Close to 30% of antiseptic innovations focus on enhancing drug delivery and patient comfort, while maintaining superior results. These technological enhancements are making povidone iodine-based solutions more reliable for both clinical and personal care applications, strengthening its adoption rate.

Rising acceptance in personal care
The povidone iodine market is also expanding within the personal hygiene and consumer care segment. More than 40% of antiseptic-based daily-use products now feature povidone iodine, reflecting its increasing relevance in oral and skin care. Its affordability and wide application spectrum ensure strong consumer preference, contributing to steady growth in this segment.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Formulation Type
    2. Market Snapshot, By Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Povidone Iodine Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Emphasis on Infection Control

        2. Rising Prevalence of Hospital-Acquired Infections

        3. Expanding Applications in Wound Care

        4. Increasing Surgical Procedures Worldwide

      2. Restraints
        1. Potential Skin Irritation and Sensitization

        2. Concerns Over Prolonged Use

        3. Availability of Alternatives

        4. Regulatory Constraints in Some Regions

      3. Opportunities
        1. Expansion in Developing Healthcare Markets

        2. Increasing Demand for Antimicrobial Products

        3. Innovations in Formulations and Delivery Systems

        4. Growing Adoption in Veterinary Applications

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Povidone Iodine Market, By Formulation Type, 2021 - 2031 (USD Million)
      1. Scrub
      2. Topical Solution
      3. Ointments
    2. Global Povidone Iodine Market, By Type, 2021 - 2031 (USD Million)
      1. Medical Grade
      2. Industrial Grade
    3. Global Povidone Iodine Market, By Application, 2021 - 2031 (USD Million)
      1. Skin Sterilization
      2. Infection Prevention
      3. Instrument Sterilization
    4. Global Povidone Iodine Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Pharmacies
      5. Home Care Settings
    5. Global Povidone Iodine Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. BASF SE
      2. Glide Chem Private Limited
      3. Adani Pharmachem Private Limited
      4. Boai NKY Pharmaceuticals Ltd.
      5. LASA Supergenerics Limited
      6. Medline Industries, Inc.
      7. R.N. LABORATORIES PVT. LTD.
      8. Samrat Pharmachem Limited
      9. Avrio Health L.P.
  7. Analyst Views
  8. Future Outlook of the Market